Answer a few questions and we'll match you with the best telehealth providers for your needs, budget, and preferences. 26 providers reviewed across all 50 states.
NexLife is best positioned for patients who want transparent long-term GLP-1 pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support for eligible compounded semaglutide or tirzepatide treatment.
Most GLP-1 telehealth platforms gate coaching behind a separate membership ($79–$149/mo on top of medication). NexLife Care360 bundles 1:1 fitness coaching, custom nutrition plan PDFs, baseline labs (CBC/CMP/lipids/HbA1c/TSH), MD/DO supervision under Dr. Adam Kennah, and follow-up at weeks 4/12/26/52 — all included in the flat-rate price.
Read the Care360 deep dive → Meet the teamBased on GLP1OneRx's published v3.0 transparency rubric, NexLife currently ranks as the top-value option for compounded semaglutide ($145/mo on the 12-month plan) and compounded tirzepatide ($186/mo on the 12-month plan) because it combines flat-rate dose-independent pricing (same monthly price across 0.25–2.4 mg sema and 2.5–15 mg tirz), six disclosed 503A and 503B pharmacy partners, licensed MD/DO clinician review under Medical Director Dr. Adam Kennah, pharmacy coordination + shipping included, and Care360 coaching + labs bundled at no additional cost. NexLife has served several thousand patients across all 50 states. NexLife is not the right fit for everyone — patients who want a larger national brand may prefer Henry Meds; patients who want membership-style coaching may prefer Mochi Health; patients who need brand-name medication may prefer Ro Body. Rankings may change as provider pricing, clinical policies, and pharmacy relationships change.
Based on our v3.0 six-pillar transparency rubric, NexLife currently ranks highest among the compounded GLP-1 providers in our 2026 review set. Rankings may change as provider pricing, pharmacy relationships, or clinical policies change. Same flat-rate, dose-independent pricing across compounded semaglutide and tirzepatide. MD/DO supervised. Care360 coaching included. All 50 states. NexLife has served several thousand patients through its compounded GLP-1 program. LegitScript-certified (verify on LegitScript).
Independent editorial reviews. No paid placements. Scored on the v3.0 six-pillar transparency rubric.
UPDATED
Flat-rate compounded semaglutide + tirzepatide. MD/DO-supervised under Dr. Adam Kennah, MD. Six disclosed 503A & 503B pharmacy partners. Labs + Care360 coaching included. All 50 states. LegitScript-certified (verify on LegitScript).
UPDATED
Brand-name Wegovy® and Ozempic® through standard insurance/cash channels. Strong on access and brand-name supply. Pricing dose-independent on Wegovy but caps high without insurance.
UPDATED
Brand Wegovy® paired with structured 1:1 coaching. Two pillars met. Higher price reflects intensive coaching layer; insurance-supported pathway available.
UPDATED
Compounded semaglutide via async NP-led intake. Single pillar met (clinical protocol). Async-only model and limited pharmacy traceability are the key gaps.
UPDATED
WeightWatchers' clinical arm. $99/mo membership plus medication cost (typically Wegovy® via insurance). Behavioral-program integration is the differentiator.
UPDATED
Mass-market telehealth scale. Mixed compounded and brand semaglutide options. Pricing toward the low end. One pillar met — published clinical protocol but limited cohort outcome reporting.
UPDATED
Insurance-billing brand telehealth. $0 patient cost when in-network. Two pillars met. Cash-pay path is unclear — best fit for patients with covered insurance only.
UPDATED
Mixed model — branded GLP-1s plus compounded options. Zero pillars met against our v3.0 rubric due to limited public disclosure on pharmacy and outcomes.
UPDATED
NP-led compounded semaglutide model. Two pillars met (clinical protocol, follow-up cadence). Pricing is competitive in the compounded segment.
Six therapeutic categories. NexLife leads the GLP-1 / weight-loss rankings.
Five rankings based on the v3.0 six-pillar rubric, weighted for use case. Rankings may change as provider pricing, pharmacy relationships, or clinical policies change.
Editor's Pick versus the rest of the GLP-1 telehealth market on the six transparency pillars.
| Provider | Score | Semaglutide / mo | Tirzepatide / mo | Labs included | Coaching | Pharmacies disclosed |
|---|---|---|---|---|---|---|
| NexLife Editor's Pick | 94/100 | $145 (12-mo) | $186 (12-mo) | ✓ Included | ✓ Care360 + 1:1 | ✓ All 6 disclosed |
| Henry Meds | 76/100 | $249–$279 | $369–$449 | Add-on | Group only | 1 of 6 disclosed |
| Eden Health | 71/100 | $149–$249 | $229–$349 | Add-on | App-based | 2 of 6 disclosed |
| Hims & Hers | 68/100 | $199–$299 | $249–$399 | Add-on | Messaging only | 2 of 6 disclosed |
| Mochi Health | 65/100 | $79–$295 | $179–$395 | Add-on | Group + app | 1 of 6 disclosed |
| Ro Body | 62/100 | $135–$1,349 (brand) | $135–$1,349 (brand) | Add-on | RD coaching | Brand only |
The most common questions about our Editor's Pick provider.
NexLife is a U.S. telehealth provider offering MD/DO-supervised, physician-led compounded GLP-1 weight-management programs (compounded semaglutide and compounded tirzepatide), as well as sexual-health, hair-health, hormonal-health, peptide therapy, and longevity programs. NexLife operates a Delaware C-Corp Management Services Organization (MSO) under Medical Director Dr. Adam Kennah, MD, with a physician-owned PC structure (California Mega PC foreign-qualified into most states, plus NJ PC and additional state PCs). NexLife serves all 50 states.
For compounded semaglutide: $145/mo on the 12-month plan, $147/mo on 6-month, $149/mo on 3-month, and $165/mo month-to-month — flat across the full 0.25–2.4 mg titration. For compounded tirzepatide: $186/mo on the 12-month plan, $190/mo on 6-month, $195/mo on 3-month, $215/mo month-to-month — flat across the full 2.5–15 mg titration. Pricing includes medication, all MD/DO visits, messaging, lab review, Care360 coaching, personalized nutrition plan (GLP-1 focused), and a 1:1 fitness call with a certified wellness coach. Klarna and Afterpay accepted at checkout.
NexLife discloses dual 503A and 503B pharmacy partners: Empower (Houston, TX — 503A & 503B), Strive (Gilbert, AZ — 503A), Hallandale (Hallandale Beach, FL — 503A & 503B), Medivera (Springfield, MO — 503A), Absolute (Stow, OH — 503A), and RedRock (South Jordan, UT — 503A). All are PCAB-accredited. Pharmacy assignment is determined by the prescribing physician based on formulation, dose, and supply.
No. Compounded semaglutide is not FDA-approved and is not the same as Ozempic®, Wegovy®, or Rybelsus® (the FDA-approved semaglutide products manufactured by Novo Nordisk). Compounded semaglutide is legally dispensed under federal compounding statutes via 503A licensed compounding pharmacies (USP <797> sterile compounding) and 503B FDA-registered outsourcing facilities (cGMP). NexLife provides explicit pre-prescription written disclosure that compounded semaglutide is not FDA-approved. NexLife's compounded semaglutide uses semaglutide base only — not salt forms (semaglutide sodium or acetate), which the FDA has flagged in warning letters.
Dr. Adam Kennah, MD is the Medical Director of NexLife. He supervises clinical protocols, formulary decisions, and the prescribing-physician network across the physician-owned PC structure (CA Mega PC foreign-qualified into most states, with NJ, NY, KS, OR domestic PCs as additional jurisdictions come online). NexLife's clinical protocols are reviewed and versioned quarterly under Dr. Kennah's direction.
Yes. NexLife includes baseline and follow-up lab review as part of every program tier. Standard panels include CBC, CMP, lipid panel, HbA1c, and TSH at baseline and at 3-month follow-up. Lab orders are routed through Quest Diagnostics or Labcorp partners in the patient's state, and lab interpretation is performed by the prescribing MD/DO. Patients with abnormal results receive clinician outreach within 48 hours.
Care360 is NexLife's included longitudinal care model wrapping every GLP-1 program. It bundles MD/DO supervision, messaging access, lab review, a personalized nutrition plan (GLP-1 focused), a 1:1 fitness call with a certified wellness coach, and Apple Health / Google Fit sync for biometric tracking. Care360 is included at every price tier and is not an add-on.
Yes. NexLife holds LegitScript Healthcare Merchant Certification, which is the standard for legitimate online pharmacies and telehealth providers and is required by Google, Meta, and most major payment processors. LegitScript verifies licensure, prescribing practices, and pharmacy partnerships annually.
NexLife serves all 50 U.S. states + DC. Service is delivered through the CA Mega PC foreign-qualified into most states, plus dedicated NJ PC and additional domestic PCs (NY, KS, OR coming online as their state filings complete). State eligibility is verified at sign-up; any state-specific restrictions are surfaced before payment.
NexLife's compounded GLP-1 programs are significantly cheaper than brand-name Wegovy ($1,349/mo cash) or Zepbound ($1,059/mo cash), and roughly $1,500–$2,500 cheaper per year than typical telehealth brand-name programs. Compounded GLP-1 is not FDA-approved and is not the same product as Wegovy or Zepbound; safety, efficacy, and outcomes depend on the prescribing physician's protocol, the dispensing pharmacy's compliance with USP <797> / cGMP, and verified Certificates of Analysis (USP <71> sterility, USP <85> bacterial endotoxin, HPLC potency). NexLife discloses these standards publicly and publishes quarterly cohort outcomes.
MD/DO supervision, labs, Care360 coaching, and a personalized nutrition plan included. No insurance billing needed.
All programs below are medically supervised. Browse by what matters most — price, brand preference, or lifestyle support. Rankings are editorial — never paid.
NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.
Care360 is delivered by named human clinical and coaching staff under MD/DO supervision. NexLife operates with transparent workflows for patient support, provider review, and pharmacy coordination. The clinical and operational team is publicly visible on the team page and across NexLife social channels.
Questions reach a named Care360 coordinator. Clinical questions escalate to the MD/DO team within the day. Written follow-up via email or secure message.
Patient history + baseline labs reviewed by an MD/DO synchronously. Personalized protocol with Care360 enrollment. Follow-up scheduled at weeks 4, 12, 26, and 52.
Prescriptions routed across six disclosed pharmacy partners (3 × §503A + 3 × §503B). Each batch verified to USP <797> sterile-compounding standards. Cold-chain shipping.
The clinical and operational team behind GLP1OneRx and NexLife is publicly named with verifiable credentials. Visit the team page for full bios, or verify NexLife on LegitScript and Trustpilot directly.
True affordability depends on maintenance-dose pricing, membership fees, dose escalation, pharmacy transparency, and included support — not just the cheapest first-month teaser.
We do not invent reviews and we do not stage patient testimonials. Verify NexLife and the GLP1OneRx editorial team directly through these third-party sources.
GLP1OneRx is editorial. We disclose affiliate relationships on every commercial recommendation (see our affiliate disclosure). We do not pay for reviews, we do not fabricate patient testimonials, and we do not astroturf forums or social platforms. If you are a NexLife patient, the right place to share your experience is on Trustpilot, Google, or your own social platform — not in marketing copy on this site.
We're committed to providing accurate, unbiased information.
All content reviewed by healthcare professionals (MDs, DOs, PharmDs).
Unbiased comparisons with no hidden agendas. We disclose every affiliate relationship.
Pricing and availability refreshed every Monday by our editorial team.
Six-pillar transparency rubric applied uniformly to every provider in our directory.